机构:[1]Department of Bioengineering, University of California, Los Angeles Los Angeles, CA 90095, USA[2]Center for Minimally Invasive Therapeutics, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA[3]Department of Chemical and Biomolecular Engineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA[4]State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China[5]School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China[6]Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China[7]Minimally Invasive Therapeutics Laboratory, Division of Vascular and Interventional Radiology, Mayo Clinic, Phoenix, AZ 85054, USA[8]Harvard–Massachusetts Institute of Technology Division of Health, Sciences and Technology, Harvard Medical School, Boston, MA 02115, USA[9]Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA[10]Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA[11]Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA
This work was supported
by the National Institutes of Health (CA214411).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|1 区材料科学
小类|1 区化学综合1 区材料科学:综合2 区纳米科技
最新[2023]版:
大类|1 区材料科学
小类|1 区化学:综合1 区材料科学:综合2 区纳米科技
第一作者:
第一作者机构:[1]Department of Bioengineering, University of California, Los Angeles Los Angeles, CA 90095, USA[2]Center for Minimally Invasive Therapeutics, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA[3]Department of Chemical and Biomolecular Engineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA
共同第一作者:
通讯作者:
通讯机构:[1]Department of Bioengineering, University of California, Los Angeles Los Angeles, CA 90095, USA[2]Center for Minimally Invasive Therapeutics, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA[3]Department of Chemical and Biomolecular Engineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA[9]Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA[10]Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA[11]Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA
推荐引用方式(GB/T 7714):
Xingwu Zhou,Moyuan Qu,Peyton Tebon,et al.Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence.[J].Advanced science (Weinheim, Baden-Wurttemberg, Germany).2020,7(19):2001447.doi:10.1002/advs.202001447.
APA:
Xingwu Zhou,Moyuan Qu,Peyton Tebon,Xing Jiang,Canran Wang...&Ali Khademhosseini.(2020).Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence..Advanced science (Weinheim, Baden-Wurttemberg, Germany),7,(19)
MLA:
Xingwu Zhou,et al."Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence.".Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7..19(2020):2001447